Green Tea EGCg may reduce Cancer Risk

Green tea (Camelia sinensis) is an abundant source of antioxidants – notably, epigallocatechin gallate (EGCg), the most potent reducer of IL-6, a powerful pro-inflammatory cytokine. Previous studies have suggested that supplements of green tea extract may confer a variety of cardiovascular and cancer protective effects.

More recently, Nagi B. Kumar, from the H. Lee Moffitt Cancer Center & Research Institute (Florida, United States), and colleagues enrolled 97 men who had premalignant prostate lesions or high-grade intraepithelial neoplasia.  Tracking for changes in  high-grade prostatic intraepithelial neoplasia (HGPIN) and/or atypical small acinar proliferation (ASAP), study participants were randomly assigned to receive either a supplement containing green tea extract (400 mg EGCg), or placebo, for one year.

Green Tea EGCg may reduce Cancer Risk 1
The researchers observed that the man who receive the green tea supplement experienced reduced combined rates of HGPIN/ASAP, as well as decreased levels of Prostate Specific Antigen (PSA). The study authors report that: ” Daily intake of a standardized, decaffeinated catechin mixture containing 400 mg EGCG per day for 1 year accumulated in plasma and was well tolerated but did not reduce the likelihood of PCa in men with baseline [high-grade prostatic intraepithelial neoplasia] or [atypical small acinar proliferation].”

EGCg is also a powerful assistant in the fight against bone loss. Both Primary Osteoporosis and bone loss due to pathological reasons (cancer), involves elevated IL-6 levels. Clear EGCg may be a beneficial nutient to anyone’s protocol should bone loss exist. Purchase HERE